Adenosine
ADENOSINE INJECTION, USP
Approved
Approval ID
a68d1eff-5cbb-4a6e-98e7-0fb6590ce2a0
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 29, 2024
Manufacturers
FDA
Akorn
DUNS: 117693100
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Adenosine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code17478-542
Application NumberANDA078076
Product Classification
M
Marketing Category
C73584
G
Generic Name
Adenosine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 29, 2024
FDA Product Classification
INGREDIENTS (3)
AdenosineActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT